Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 9,600 shares at $13.78 ($134K) on 2007-11-14, disclosed to the SEC on 2007-11-15.
Scheduled sale ($134k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.73 | 175 | $2K | 1.8% |
| 2 | $13.74 | 25 | $344 | 0.3% |
| 3 | $13.78 | 100 | $1K | 1.0% |
| 4 | $13.81 | 100 | $1K | 1.0% |
| 5 | $13.82 | 200 | $3K | 2.1% |
| 6 | $13.84 | 200 |
| $3K |
| 2.1% |
| 7 | $13.85 | 100 | $1K | 1.0% |
| 8 | $13.86 | 600 | $8K | 6.2% |
| 9 | $13.88 | 100 | $1K | 1.0% |
| 10 | $13.89 | 300 | $4K | 3.1% |
| 11 | $13.90 | 200 | $3K | 2.1% |
| 12 | $13.91 | 200 | $3K | 2.1% |
| 13 | $13.92 | 100 | $1K | 1.0% |
| 14 | $13.93 | 300 | $4K | 3.1% |
| 15 | $13.94 | 400 | $6K | 4.2% |
| 16 | $13.95 | 200 | $3K | 2.1% |
| 17 | $13.96 | 400 | $6K | 4.2% |
| 18 | $13.97 | 400 | $6K | 4.2% |
| 19 | $13.98 | 700 | $10K | 7.3% |
| 20 | $13.99 | 800 | $11K | 8.3% |
| 21 | $14.00 | 500 | $7K | 5.2% |
| 22 | $14.01 | 100 | $1K | 1.0% |
| 23 | $14.02 | 300 | $4K | 3.1% |
| 24 | $14.03 | 1,200 | $17K | 12.6% |
| 25 | $14.04 | 900 | $13K | 9.4% |
| 26 | $14.06 | 100 | $1K | 1.0% |
| 27 | $14.07 | 200 | $3K | 2.1% |
| 28 | $14.09 | 300 | $4K | 3.2% |
| 29 | $14.11 | 400 | $6K | 4.2% |
| Total | $13.97 avg | 9,600 | $134K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |